ProQR Therapeutics (PRQR) EPS (Basic) Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.38% |
| Sep 30, 2025 | -11.44% |
| Jun 30, 2025 | -41.97% |
| Mar 31, 2025 | -1,165.70% |
| Dec 31, 2024 | -44.14% |
| Sep 30, 2024 | -24.39% |
| Jun 30, 2024 | -3.24% |
| Mar 31, 2024 | -16.69% |
| Dec 31, 2023 | 30.66% |
| Sep 30, 2023 | -21.80% |
| Jun 30, 2023 | -24.20% |
| Mar 31, 2023 | -1,108.33% |
| Dec 31, 2022 | -18.69% |
| Sep 30, 2022 | -1,225.91% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -38.13% |
| Dec 31, 2021 | 8.42% |
| Sep 30, 2021 | -769.00% |
| Jun 30, 2021 | -850.52% |
| Mar 31, 2021 | -959.67% |
| Dec 31, 2020 | 1.13% |
| Sep 30, 2020 | -841.84% |
| Jun 30, 2020 | -679.28% |
| Mar 31, 2020 | 96.92% |
| Dec 31, 2019 | -31.51% |
| Sep 30, 2019 | -680.99% |
| Mar 31, 2019 | -965.04% |
| Dec 31, 2018 | 83.11% |
| Sep 30, 2018 | -22.49% |